$SGNT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sagent Pharmaceuticals, Inc.. Get notifications about new insider transactions in Sagent Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | U | 21.75 | 34,961 | 760,402 | 0 | 35 K to 0 (-100.00 %) |
| Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | U | 21.75 | 2,978,803 | 64,788,965 | 0 | 3 M to 0 (-100.00 %) |
| Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 17 | 230 | 25,320 | 25.3 K to 25.3 K (-0.07 %) |
| Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 2,299 | 31,151 | 3,456,332 | 3.5 M to 3.5 M (-0.07 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 20.10 | 55,000 | 1,105,500 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 16.45 | 12,067 | 198,502 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 20.16 | 10,638 | 214,462 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 14.61 | 34,783 | 508,180 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | D | 21.75 | 27,206 | 591,731 | 0 | 27.2 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | U | 21.75 | 7,857 | 170,890 | 27,206 | 35.1 K to 27.2 K (-22.41 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | D | 21.75 | 3,665 | 79,714 | 35,063 | 38.7 K to 35.1 K (-9.46 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Option Exercise | D | 14.61 | 108,696 | 1,588,049 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Sell | D | 21.75 | 92,527 | 2,012,462 | 0 | 92.5 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Sell | D | 21.75 | 9,459 | 205,733 | 92,527 | 102 K to 92.5 K (-9.27 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 11.60 | 6,379 | 73,996 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Sell | U | 21.75 | 7,097 | 154,360 | 0 | 7.1 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 2.51 | 607 | 1,524 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 4.23 | 6,870 | 29,060 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 4.31 | 5,103 | 21,994 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 11.60 | 5,103 | 59,195 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 16.45 | 9,969 | 163,990 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 20.16 | 3,546 | 71,487 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 14.61 | 6,522 | 95,286 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 15.02 | 10,608 | 159,332 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Sell | D | 21.75 | 8,073 | 175,588 | 0 | 8.1 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Sell | U | 21.75 | 2,583 | 56,180 | 8,073 | 10.7 K to 8.1 K (-24.24 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 11.60 | 6,379 | 73,996 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Sell | U | 21.75 | 7,097 | 154,360 | 0 | 7.1 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 11.60 | 5,103 | 59,195 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 433,770 | 9,434,498 | 0 | 433.8 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 2,000 | 43,500 | 0 | 2 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 8,050 | 175,088 | 0 | 8.1 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Gift | G | 0.00 | 4,150 | 0 | 8,050 | 12.2 K to 8.1 K (-34.02 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BRYNJELSEN SEAN | EVP, Business Devel ... | Option Exercise | D | 12.19 | 21,016 | 256,185 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BRYNJELSEN SEAN | EVP, Business Devel ... | Sell | D | 21.75 | 9,844 | 214,107 | 0 | 9.8 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Option Exercise | D | 15.81 | 20,000 | 316,200 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Option Exercise | D | 14.61 | 10,507 | 153,507 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Sell | D | 21.75 | 4,962 | 107,924 | 0 | 5 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Sell | U | 21.75 | 600 | 13,050 | 0 | 600 to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Sell | U | 21.75 | 1,000 | 21,750 | 4,962 | 6 K to 5 K (-16.77 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 592 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Sell | U | 21.75 | 2,041 | 44,392 | 0 | 2 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Sell | D | 21.75 | 2,283 | 49,655 | 2,041 | 4.3 K to 2 K (-52.80 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Harmon J Frank | EVP, Global Operati ... | Option Exercise | D | 13.46 | 18,897 | 254,354 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Harmon J Frank | EVP, Global Operati ... | Sell | D | 21.75 | 8,915 | 193,901 | 0 | 8.9 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | D | 16.45 | 8,604 | 141,536 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | D | 20.16 | 8,865 | 178,718 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | D | 14.61 | 10,507 | 153,507 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Sell | D | 21.75 | 4,962 | 107,924 | 0 | 5 K to 0 (-100.00 %) |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | D | 0.00 | 2,228 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
| Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Sell | D | 21.75 | 742 | 16,139 | 0 | 742 to 0 (-100.00 %) |
| Aug 05 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Payment of Exercise | F | 21.74 | 4,271 | 92,852 | 101,986 | 106.3 K to 102 K (-4.02 %) |
| Jul 13 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | M | 0.00 | 591 | 0 | 592 | ||
| Jul 13 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Buy | M | 0.00 | 591 | 0 | 5,651 | 5.1 K to 5.7 K (+11.68 %) | |
| Jun 28 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | A | 15.02 | 10,608 | 159,332 | 10,608 | |
| Jun 28 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Grant | A | 0.00 | 4,993 | 0 | 10,656 | 5.7 K to 10.7 K (+88.17 %) |
| Apr 06 2016 | SGNT | Sagent Pharmaceuti ... | BRYNJELSEN SEAN | EVP, Business Deve ... | Option Exercise | A | 12.19 | 21,016 | 256,185 | 21,016 | |
| Apr 06 2016 | SGNT | Sagent Pharmaceuti ... | BRYNJELSEN SEAN | EVP, Business Deve ... | Grant | A | 0.00 | 9,844 | 0 | 9,844 | 0 to 9.8 K |
| Mar 22 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 12.39 | 66 | 818 | 48,690 | 48.8 K to 48.7 K (-0.14 %) |
| Mar 16 2016 | SGNT | Sagent Pharmaceuti ... | Harmon J Frank | EVP, Global Operati ... | Option Exercise | A | 13.46 | 18,897 | 254,354 | 18,897 | |
| Mar 16 2016 | SGNT | Sagent Pharmaceuti ... | Harmon J Frank | EVP, Global Operati ... | Grant | A | 0.00 | 8,915 | 0 | 8,915 | 0 to 8.9 K |
| Feb 26 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 14.58 | 402 | 5,861 | 53,292 | 53.7 K to 53.3 K (-0.75 %) |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 14.58 | 334 | 4,870 | 38,728 | 39.1 K to 38.7 K (-0.86 %) |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 14.58 | 373 | 5,438 | 48,756 | 49.1 K to 48.8 K (-0.76 %) |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 14.58 | 335 | 4,884 | 39,172 | 39.5 K to 39.2 K (-0.85 %) |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Option Exercise | M | 0.00 | 230 | 0 | 691 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Option Exercise | M | 0.00 | 460 | 0 | 1,381 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Buy | M | 0.00 | 230 | 0 | 7,097 | 6.9 K to 7.1 K (+3.35 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Buy | M | 0.00 | 460 | 0 | 6,867 | 6.4 K to 6.9 K (+7.18 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 230 | 0 | 691 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 460 | 0 | 1,381 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 230 | 0 | 12,200 | 12 K to 12.2 K (+1.92 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 460 | 0 | 11,970 | 11.5 K to 12 K (+4.00 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | M | 0.00 | 230 | 0 | 691 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | M | 0.00 | 460 | 0 | 1,381 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Buy | M | 0.00 | 230 | 0 | 5,060 | 4.8 K to 5.1 K (+4.76 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Buy | M | 0.00 | 460 | 0 | 4,830 | 4.4 K to 4.8 K (+10.53 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Option Exercise | M | 0.00 | 230 | 0 | 691 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Option Exercise | M | 0.00 | 460 | 0 | 1,381 | ||
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Buy | M | 0.00 | 230 | 0 | 7,097 | 6.9 K to 7.1 K (+3.35 %) | |
| Feb 25 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Buy | M | 0.00 | 460 | 0 | 6,867 | 6.4 K to 6.9 K (+7.18 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | A | 14.61 | 10,507 | 153,507 | 10,507 | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Grant | A | 0.00 | 4,962 | 0 | 4,962 | 0 to 5 K |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | SHEA THOMAS JOSEPH | VP, Global Alliance ... | Option Exercise | A | 14.61 | 10,507 | 153,507 | 10,507 | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | SHEA THOMAS JOSEPH | VP, Global Alliance ... | Grant | A | 0.00 | 4,962 | 0 | 10,442 | 5.5 K to 10.4 K (+90.55 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Option Exercise | A | 14.61 | 108,696 | 1,588,049 | 108,696 | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Grant | A | 0.00 | 51,335 | 0 | 106,257 | 54.9 K to 106.3 K (+93.47 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | M | 0.00 | 567 | 0 | 0 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | M | 0.00 | 760 | 0 | 760 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Buy | M | 0.00 | 567 | 0 | 4,370 | 3.8 K to 4.4 K (+14.91 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Buy | M | 0.00 | 760 | 0 | 3,803 | 3 K to 3.8 K (+24.98 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Option Exercise | A | 14.61 | 17,391 | 254,083 | 17,391 | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Grant | A | 0.00 | 8,214 | 0 | 39,507 | 31.3 K to 39.5 K (+26.25 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 13.00 | 335 | 4,355 | 31,293 | 31.6 K to 31.3 K (-1.06 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 14.61 | 449 | 6,560 | 31,628 | 32.1 K to 31.6 K (-1.40 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Option Exercise | M | 0.00 | 567 | 0 | 0 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Option Exercise | M | 0.00 | 760 | 0 | 760 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Buy | M | 0.00 | 567 | 0 | 6,407 | 5.8 K to 6.4 K (+9.71 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Buy | M | 0.00 | 760 | 0 | 5,840 | 5.1 K to 5.8 K (+14.96 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 567 | 0 | 0 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 760 | 0 | 760 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 567 | 0 | 11,510 | 10.9 K to 11.5 K (+5.18 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 760 | 0 | 10,943 | 10.2 K to 10.9 K (+7.46 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Option Exercise | M | 0.00 | 567 | 0 | 0 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Option Exercise | M | 0.00 | 760 | 0 | 760 | ||
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Buy | M | 0.00 | 567 | 0 | 6,407 | 5.8 K to 6.4 K (+9.71 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Buy | M | 0.00 | 760 | 0 | 5,840 | 5.1 K to 5.8 K (+14.96 %) | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 14.61 | 486 | 7,100 | 53,694 | 54.2 K to 53.7 K (-0.90 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 14.61 | 744 | 10,870 | 54,180 | 54.9 K to 54.2 K (-1.35 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Option Exercise | A | 14.61 | 17,391 | 254,083 | 17,391 | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Grant | A | 0.00 | 8,214 | 0 | 49,129 | 40.9 K to 49.1 K (+20.08 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 14.61 | 406 | 5,932 | 40,915 | 41.3 K to 40.9 K (-0.98 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 14.61 | 637 | 9,307 | 41,321 | 42 K to 41.3 K (-1.52 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | A | 14.61 | 34,783 | 508,180 | 34,783 | |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Grant | A | 0.00 | 16,427 | 0 | 39,062 | 22.6 K to 39.1 K (+72.57 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 14.61 | 468 | 6,837 | 22,635 | 23.1 K to 22.6 K (-2.03 %) |
| Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 14.61 | 637 | 9,307 | 23,103 | 23.7 K to 23.1 K (-2.68 %) |
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Option Exercise | M | 0.00 | 930 | 0 | 1,860 | ||
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Buy | M | 0.00 | 930 | 0 | 5,080 | 4.2 K to 5.1 K (+22.41 %) | |
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Option Exercise | M | 0.00 | 930 | 0 | 1,860 | ||
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Buy | M | 0.00 | 930 | 0 | 3,043 | 2.1 K to 3 K (+44.01 %) | |
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 15.16 | 452 | 6,852 | 32,077 | 32.5 K to 32.1 K (-1.39 %) |
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Option Exercise | M | 0.00 | 930 | 0 | 1,860 | ||
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Buy | M | 0.00 | 930 | 0 | 10,183 | 9.3 K to 10.2 K (+10.05 %) | |
| Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Option Exercise | M | 0.00 | 930 | 0 | 1,860 |